{"id":"human-albumin-5","safety":{"commonSideEffects":[{"rate":"null","effect":"Hypotension"},{"rate":"null","effect":"Anaphylaxis"},{"rate":"null","effect":"Thrombosis"}]},"_chembl":{"chemblId":"CHEMBL1201451","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Human albumin 5% is used to increase blood volume and maintain blood pressure in patients with severe blood loss or shock. It also helps to stabilize the blood volume and prevent shock in patients undergoing surgery or with severe burns.","oneSentence":"Human albumin 5% acts as a volume expander and stabilizer of blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:46:33.929Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Severe blood loss or shock"},{"name":"Surgery"},{"name":"Severe burns"}]},"trialDetails":[{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT06998940","phase":"PHASE3","title":"Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations","status":"RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2026-04-01","conditions":"Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8","enrollment":94},{"nctId":"NCT07183371","phase":"PHASE2","title":"A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oxford","startDate":"2025-12-15","conditions":"Malaria,Falciparum","enrollment":360},{"nctId":"NCT05491512","phase":"PHASE2","title":"A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-08-04","conditions":"HPV, Throat Cancer, Oropharyngeal Carcinoma","enrollment":121},{"nctId":"NCT07449364","phase":"NA","title":"Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty Patient","status":"COMPLETED","sponsor":"Daewoong Group Indonesia","startDate":"2025-03-24","conditions":"Frailty in Older Adults","enrollment":10},{"nctId":"NCT07408583","phase":"PHASE1, PHASE2","title":"Prenatal Transplantation for Fetuses With Fanconi Anemia","status":"NOT_YET_RECRUITING","sponsor":"Agnieszka Czechowicz","startDate":"2026-07","conditions":"Fanconi Anemia, Anemia, Hypoplastic, Congenital, Congenital Bone Marrow Failure Syndromes","enrollment":12},{"nctId":"NCT05722938","phase":"PHASE3","title":"Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)","status":"RECRUITING","sponsor":"Biotest","startDate":"2023-09-09","conditions":"Community-acquired Pneumonia","enrollment":590},{"nctId":"NCT05857371","phase":"PHASE2","title":"Safety and Potential Effect of Innovative Treatment by Adjuvant Injection of Stromal Vascular Fraction From Autologous Adipose Tissue of URethral Stenosis With Endoscopic Urethrotomy","status":"RECRUITING","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2024-03-13","conditions":"Urethral Stenosis","enrollment":20},{"nctId":"NCT05352750","phase":"PHASE1","title":"Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sonnet BioTherapeutics","startDate":"2022-04-20","conditions":"Advanced Solid Tumor, Soft Tissue Sarcoma Adult","enrollment":42},{"nctId":"NCT05624996","phase":"PHASE3","title":"Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"NRG Oncology","startDate":"2023-07-12","conditions":"Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8","enrollment":474},{"nctId":"NCT07020715","phase":"PHASE2","title":"A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2026-03-01","conditions":"Multiple Sclerosis","enrollment":14},{"nctId":"NCT03702920","phase":"PHASE3","title":"Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5%","status":"TERMINATED","sponsor":"Grifols Therapeutics LLC","startDate":"2019-02-21","conditions":"Acute-On-Chronic Liver Failure","enrollment":275},{"nctId":"NCT04390399","phase":"PHASE2","title":"Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"ImmunityBio, Inc.","startDate":"2020-07-21","conditions":"Pancreatic Cancer","enrollment":328},{"nctId":"NCT03818854","phase":"PHASE2","title":"Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"Michael A. Matthay","startDate":"2019-11-26","conditions":"Respiratory Distress Syndrome, Adult","enrollment":120},{"nctId":"NCT07150767","phase":"PHASE1","title":"A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) Combined With Neoadjuvant Treatment for Locally Advanced Breast Cancer","status":"WITHDRAWN","sponsor":"Beijing Bio-Targeting Therapeutics Technology Co., Ltd","startDate":"2025-03-26","conditions":"Locally Advanced Breast Cancer (LABC)","enrollment":""},{"nctId":"NCT04701034","phase":"PHASE2","title":"Intravenous Immunoglobulin and Prednisolone for RPL After ART.","status":"COMPLETED","sponsor":"Aalborg University Hospital","startDate":"2021-01-28","conditions":"Habitual Abortion, Recurrent Pregnancy Loss, Fertility Disorders","enrollment":80},{"nctId":"NCT03734029","phase":"PHASE3","title":"Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daiichi Sankyo","startDate":"2018-12-27","conditions":"Breast Cancer","enrollment":557},{"nctId":"NCT05854641","phase":"PHASE4","title":"Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease","status":"RECRUITING","sponsor":"Cell Biopeutics Resources Sdn Bhd","startDate":"2024-01-01","conditions":"Critical Limb Ischemia, Peripheral Arterial Disease","enrollment":10},{"nctId":"NCT05854615","phase":"PHASE4","title":"Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease","status":"RECRUITING","sponsor":"Cell Biopeutics Resources Sdn Bhd","startDate":"2024-01-01","conditions":"Critical Limb Ischemia, Buerger's Disease","enrollment":3},{"nctId":"NCT04869397","phase":"PHASE2","title":"Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells","status":"TERMINATED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2021-06-14","conditions":"Covid19","enrollment":19},{"nctId":"NCT02219165","phase":"PHASE2","title":"Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot Study","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2015-01-08","conditions":"Toxic Shock Syndrome","enrollment":30},{"nctId":"NCT06715605","phase":"PHASE2","title":"A Clinical Trial Evaluating the Safety and Efficacy of Myelin-peptide Loaded tolDC as Treatment for MS","status":"WITHDRAWN","sponsor":"University Hospital, Antwerp","startDate":"2025-04-30","conditions":"Multiple Sclerosis","enrollment":""},{"nctId":"NCT04865107","phase":"PHASE2","title":"Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2021-04-27","conditions":"Covid19, Acute Respiratory Distress Syndrome","enrollment":22},{"nctId":"NCT05239182","phase":"PHASE2","title":"9-ING-41 Plus Retifanlimab and Gemcitabine/Nab-Paclitaxel in Patients With Advanced Pancreatic Adenocarcinoma","status":"TERMINATED","sponsor":"Anwaar Saeed","startDate":"2022-01-26","conditions":"Pancreatic Adenocarcinoma","enrollment":7},{"nctId":"NCT00199862","phase":"NA","title":"Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2004-02","conditions":"Colorectal Neoplasms, Colorectal Cancer, Colorectal Tumor","enrollment":30},{"nctId":"NCT00868530","phase":"PHASE3","title":"Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-09","conditions":"Hemophilia A","enrollment":53},{"nctId":"NCT05531149","phase":"PHASE3","title":"Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia","status":"TERMINATED","sponsor":"Biotest","startDate":"2022-12-22","conditions":"Respiratory Infection, Pneumonia, Community-acquired Pneumonia","enrollment":107},{"nctId":"NCT05775198","phase":"NA","title":"Effect of Intrauterine Administration of Autologous PBMC Modulated With IFNt on IVF Outcome","status":"RECRUITING","sponsor":"Nadezhda Women's Health Hospital","startDate":"2023-03-01","conditions":"Infertility, Female, IVF","enrollment":300},{"nctId":"NCT06654687","phase":"NA","title":"Transthoracic Echocardiographic Monitoring of Cardiac Output Effects of Colloid Preload and Crystalloid Coload During Cesarean Delivery Under Spinal Anesthesia","status":"COMPLETED","sponsor":"Sameh Fathy","startDate":"2024-10-27","conditions":"Pregnancy, Cesarean Delivery, Spinal Anesthesia Induced Hypotension","enrollment":162},{"nctId":"NCT06853522","phase":"EARLY_PHASE1","title":"hucMSCs Exosomes for the Treatment of Active Ulcerative Colitis","status":"NOT_YET_RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2025-05-30","conditions":"Ulcerative Colitis (UC)","enrollment":40},{"nctId":"NCT05964361","phase":"PHASE1, PHASE2","title":"First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2023-12-06","conditions":"Esophageal Cancer, Pancreas Cancer, Ovarian Cancer","enrollment":10},{"nctId":"NCT04963569","phase":"","title":"Mechanistic Inflammatory Sub-study Embedded Within the Albumin vs Balanced Crystalloid Trial","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2021-12-13","conditions":"Sepsis","enrollment":26},{"nctId":"NCT03378102","phase":"EARLY_PHASE1","title":"Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation","status":"RECRUITING","sponsor":"Mari Dallas","startDate":"2019-01-04","conditions":"Allogeneic Hematopoietic Stem Cell Transplantation","enrollment":20},{"nctId":"NCT03941405","phase":"PHASE2","title":"Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT)","status":"COMPLETED","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2020-02-01","conditions":"Hyponatremia With Excess Extracellular Fluid Volume, Cirrhosis, Liver","enrollment":52},{"nctId":"NCT03169790","phase":"PHASE1, PHASE2","title":"QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2017-12","conditions":"Non Hodgkin Lymphoma","enrollment":""},{"nctId":"NCT03169764","phase":"PHASE1, PHASE2","title":"QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2017-12","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":""},{"nctId":"NCT03175666","phase":"PHASE1, PHASE2","title":"QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2017-12","conditions":"Triple Negative Breast Cancer","enrollment":""},{"nctId":"NCT03563144","phase":"PHASE2","title":"QUILT-3.088: NANT Pancreatic Cancer Vaccine","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2018-08","conditions":"Metastatic Pancreatic Cancer","enrollment":""},{"nctId":"NCT03167177","phase":"PHASE1, PHASE2","title":"QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2017-12","conditions":"Melanoma","enrollment":""},{"nctId":"NCT03554109","phase":"PHASE2","title":"QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2018-09","conditions":"Triple Negative Breast Cancer (TNBC)","enrollment":""},{"nctId":"NCT03197571","phase":"PHASE1, PHASE2","title":"QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2017-12","conditions":"Urothelial Carcinoma","enrollment":""},{"nctId":"NCT03574649","phase":"PHASE2","title":"QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2018-06","conditions":"Non Small Cell Lung Cancer","enrollment":""},{"nctId":"NCT03167164","phase":"PHASE1, PHASE2","title":"QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy","status":"WITHDRAWN","sponsor":"ImmunityBio, Inc.","startDate":"2017-12","conditions":"Merkel Cell Carcinoma","enrollment":""},{"nctId":"NCT04466098","phase":"PHASE2","title":"Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2020-07-30","conditions":"Acute Respiratory Distress Syndrome, ARDS (Moderate or Severe), COVID-19 Pneumonia","enrollment":8},{"nctId":"NCT02986698","phase":"PHASE1","title":"In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2017-10-05","conditions":"Alpha Thalassemia Major, Hemoglobinopathy; with Thalassemia, Hemoglobinopathies","enrollment":6},{"nctId":"NCT04118556","phase":"PHASE2","title":"Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT","status":"RECRUITING","sponsor":"Mats Remberger","startDate":"2021-12-01","conditions":"GVHD, Acute","enrollment":50},{"nctId":"NCT03329248","phase":"PHASE1, PHASE2","title":"QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy","status":"TERMINATED","sponsor":"ImmunityBio, Inc.","startDate":"2017-11-06","conditions":"Pancreatic Cancer","enrollment":6},{"nctId":"NCT03563157","phase":"PHASE1, PHASE2","title":"QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine","status":"TERMINATED","sponsor":"ImmunityBio, Inc.","startDate":"2018-09-28","conditions":"Colorectal Cancer Metastatic, mCRC","enrollment":2},{"nctId":"NCT02618902","phase":"PHASE1","title":"A \"negative\"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical Trial","status":"COMPLETED","sponsor":"University Hospital, Antwerp","startDate":"2017-05-30","conditions":"Multiple Sclerosis","enrollment":9},{"nctId":"NCT06107335","phase":"PHASE4","title":"Effect of Albumin Versus Routine Care on Hemodynamic Response and Stability in Patients With Preeclampsia Guided by a Non-invasive Hemodynamic Monitoring System During Cesarean Delivery With Spinal Anesthesia","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2025-07-01","conditions":"Pre-Eclampsia","enrollment":62},{"nctId":"NCT05604521","phase":"PHASE1","title":"A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI","status":"TERMINATED","sponsor":"Sanaria Inc.","startDate":"2022-12-06","conditions":"Malaria, Malaria,Falciparum","enrollment":31},{"nctId":"NCT04540094","phase":"PHASE3","title":"Feasibility of 5% Albumin Compared With Balanced Crystalloid, as Intravenous Fluid Resuscitation in Adult Patients With Sepsis, Presenting as an Emergency to Hospital","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2021-06-01","conditions":"Sepsis","enrollment":300},{"nctId":"NCT06610773","phase":"PHASE1, PHASE2","title":"HUC-MSC for Treatment of High-risk HPV Infection","status":"RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2024-03-01","conditions":"Human Papillomavirus Viruses, Mesenchymal Stem Cells","enrollment":60},{"nctId":"NCT03886506","phase":"","title":"Expanded Access Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization","status":"NO_LONGER_AVAILABLE","sponsor":"Pluristem Ltd.","startDate":"","conditions":"Critical Limb Ischemia (CLI)","enrollment":""},{"nctId":"NCT03365414","phase":"PHASE3","title":"A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe POTS","status":"WITHDRAWN","sponsor":"University of Alberta","startDate":"2022-01","conditions":"Postural Orthostatic Tachycardia Syndrome","enrollment":""},{"nctId":"NCT04390503","phase":"PHASE2","title":"Convalescent Plasma for Early Treatment of COVID-19","status":"TERMINATED","sponsor":"Andrew Eisenberger","startDate":"2021-03-12","conditions":"SARS-CoV 2, COVID-19","enrollment":223},{"nctId":"NCT03586869","phase":"PHASE1, PHASE2","title":"QUILT-3.080: NANT Pancreatic Cancer Vaccine","status":"TERMINATED","sponsor":"ImmunityBio, Inc.","startDate":"2018-07-17","conditions":"Pancreatic Cancer","enrollment":3},{"nctId":"NCT03387085","phase":"PHASE1, PHASE2","title":"QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.","status":"TERMINATED","sponsor":"ImmunityBio, Inc.","startDate":"2018-03-19","conditions":"Triple Negative Breast Cancer","enrollment":9},{"nctId":"NCT03387111","phase":"PHASE1, PHASE2","title":"QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed","status":"TERMINATED","sponsor":"ImmunityBio, Inc.","startDate":"2018-01-09","conditions":"Squamous Cell Carcinoma","enrollment":4},{"nctId":"NCT06534450","phase":"PHASE3","title":"The Effects Of Therapeutic Plasma Exchange (TPE) On Age Related Biomarkers And Epigenetics","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dobri Kiprov","startDate":"2022-09-12","conditions":"Aging","enrollment":40},{"nctId":"NCT06126354","phase":"PHASE1","title":"Dexamethasone/Pancreatic Clamp P&F","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2024-07-01","conditions":"Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease","enrollment":""},{"nctId":"NCT03136406","phase":"PHASE1, PHASE2","title":"QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy","status":"TERMINATED","sponsor":"ImmunityBio, Inc.","startDate":"2017-08-11","conditions":"Pancreatic Cancer","enrollment":3},{"nctId":"NCT03387098","phase":"PHASE1, PHASE2","title":"QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy","status":"TERMINATED","sponsor":"ImmunityBio, Inc.","startDate":"2017-12-28","conditions":"Pancreatic Cancer","enrollment":4},{"nctId":"NCT05765084","phase":"PHASE1, PHASE2","title":"Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma","status":"RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2023-02-24","conditions":"Malignant Pleural Mesothelioma","enrollment":15},{"nctId":"NCT05985863","phase":"PHASE1, PHASE2","title":"Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure","status":"RECRUITING","sponsor":"Beijing 302 Hospital","startDate":"2023-09-30","conditions":"Acute-On-Chronic Liver Failure","enrollment":150},{"nctId":"NCT05726136","phase":"PHASE4","title":"Fluid Challenge and Plasma Volume, During Surgery","status":"RECRUITING","sponsor":"Joachim Zdolsek","startDate":"2023-10-23","conditions":"Colorectal Cancer, Urologic Cancer, Gynecologic Cancer","enrollment":60},{"nctId":"NCT06202261","phase":"PHASE1, PHASE2","title":"A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer","status":"RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2023-04-13","conditions":"Metastatic Breast Cancer, Recurrent Breast Cancer, Advanced Malignancies","enrollment":154},{"nctId":"NCT05015686","phase":"PHASE3","title":"Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old","status":"ENROLLING_BY_INVITATION","sponsor":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","startDate":"2021-09-30","conditions":"Varicella","enrollment":2400},{"nctId":"NCT03878524","phase":"PHASE1","title":"Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2020-04-01","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Anatomic Stage IV Breast Cancer AJCC v8, Anemia","enrollment":2},{"nctId":"NCT03897205","phase":"PHASE2","title":"An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients","status":"COMPLETED","sponsor":"Hansa Biopharma AB","startDate":"2019-04-30","conditions":"Kidney Transplant Rejection","enrollment":30},{"nctId":"NCT03950414","phase":"PHASE1","title":"A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients","status":"TERMINATED","sponsor":"University of Wisconsin, Madison","startDate":"2019-09-27","conditions":"Cytomegalovirus Infections, Solid Organ Transplant","enrollment":2},{"nctId":"NCT04356859","phase":"NA","title":"The Acute Burn ResUscitation Multicenter Prospective Trial","status":"UNKNOWN","sponsor":"American Burn Association","startDate":"2021-04-22","conditions":"Burn Injury","enrollment":400},{"nctId":"NCT02882074","phase":"NA","title":"Endothelial Function After Cardiac Surgery","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2016-06","conditions":"Endothelial Dysfunction","enrollment":85},{"nctId":"NCT06224777","phase":"PHASE2, PHASE3","title":"Comparison of Fluid Resuscitation in Pediatric Burn Patients Using Crystalloids and With Albumin on Day Two.","status":"COMPLETED","sponsor":"King Edward Medical University","startDate":"2022-01-01","conditions":"Burns","enrollment":90},{"nctId":"NCT06219096","phase":"NA","title":"Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2023-12-10","conditions":"Malignant Tumor of Liver, Randomized Controlled Trial","enrollment":100},{"nctId":"NCT05238831","phase":"EARLY_PHASE1","title":"SMMART Adaptive Clinical Treatment (ACT) Trial","status":"WITHDRAWN","sponsor":"OHSU Knight Cancer Institute","startDate":"2023-01-30","conditions":"Advanced Breast Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Ovarian Carcinoma","enrollment":""},{"nctId":"NCT00006099","phase":"PHASE1","title":"Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer","status":"TERMINATED","sponsor":"Ludwig Institute for Cancer Research","startDate":"2000-08-02","conditions":"Ovarian Cancer","enrollment":1},{"nctId":"NCT00006046","phase":"PHASE1","title":"Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer","status":"TERMINATED","sponsor":"Ludwig Institute for Cancer Research","startDate":"2000-07-12","conditions":"Colorectal Cancer","enrollment":7},{"nctId":"NCT04660396","phase":"","title":"Monitoring Outpatient Blood VolumE in Heart Failure","status":"COMPLETED","sponsor":"Daxor Corporation","startDate":"2021-09-16","conditions":"Heart Failure","enrollment":15},{"nctId":"NCT03840915","phase":"PHASE1, PHASE2","title":"M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)","status":"COMPLETED","sponsor":"EMD Serono Research & Development Institute, Inc.","startDate":"2019-04-02","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":70},{"nctId":"NCT03818737","phase":"PHASE3","title":"Multicenter Trial of Stem Cell Therapy for Osteoarthritis (MILES)","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-03-28","conditions":"Osteoarthritis","enrollment":475},{"nctId":"NCT01084083","phase":"PHASE2","title":"Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2010-08-11","conditions":"Head and Neck Cancer, Precancerous Condition","enrollment":90},{"nctId":"NCT05445674","phase":"PHASE2","title":"Plasma Exchange Therapy for Post- COVID-19 Condition: A Pilot, Randomized Double-Blind Study","status":"COMPLETED","sponsor":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","startDate":"2022-09-22","conditions":"Post-COVID19 Condition","enrollment":50},{"nctId":"NCT02620865","phase":"PHASE1, PHASE2","title":"BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer","status":"COMPLETED","sponsor":"Barbara Ann Karmanos Cancer Institute","startDate":"2015-12","conditions":"Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer","enrollment":2},{"nctId":"NCT02580201","phase":"PHASE4","title":"A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age","status":"COMPLETED","sponsor":"Fidec Corporation","startDate":"2015-11","conditions":"Poliomyelitis","enrollment":154},{"nctId":"NCT02837094","phase":"PHASE1","title":"Enhanced Epidermal Antigen Specific Immunotherapy Trial -1","status":"COMPLETED","sponsor":"Cardiff University","startDate":"2016-09-29","conditions":"Type 1 Diabetes","enrollment":6},{"nctId":"NCT05743751","phase":"NA","title":"Normothermic Machine Perfusion (NMP) Versus Hypothermic Machine Perfusion (HMP) in Human Kidney Transplantation","status":"UNKNOWN","sponsor":"Zhang Tianyu","startDate":"2023-03-03","conditions":"Kidney Transplantation","enrollment":60},{"nctId":"NCT02192502","phase":"PHASE3","title":"Use of 6% Hydroxyethylstarch (130/0.4) in Cardiac Surgical Patients","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2015-03","conditions":"Postoperative Kidney Injury","enrollment":149},{"nctId":"NCT01376778","phase":"PHASE3","title":"A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)","status":"COMPLETED","sponsor":"The George Washington University Biostatistics Center","startDate":"2012-04","conditions":"Congenital Cytomegalovirus Infection, Maternal Cytomegalovirus Infection","enrollment":399},{"nctId":"NCT04576728","phase":"PHASE2","title":"Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19","status":"COMPLETED","sponsor":"Biotest","startDate":"2020-10-06","conditions":"Covid19","enrollment":166},{"nctId":"NCT05631444","phase":"PHASE1, PHASE2","title":"Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia","status":"COMPLETED","sponsor":"Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle","startDate":"2019-01-01","conditions":"Chronic Limb-threatening Ischemia, Diabetes Mellitus","enrollment":24},{"nctId":"NCT01436292","phase":"PHASE4","title":"Hypoalbuminemia in Burn Patients","status":"WITHDRAWN","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2011-09","conditions":"Second or Third Degree Burns","enrollment":""},{"nctId":"NCT05558722","phase":"PHASE2","title":"Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2022-11-30","conditions":"Breast Cancer Stage II","enrollment":30},{"nctId":"NCT04296474","phase":"PHASE1, PHASE2","title":"Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass","status":"COMPLETED","sponsor":"Lars Olaf Cardell","startDate":"2018-05-15","conditions":"Allergic Rhinitis","enrollment":34},{"nctId":"NCT05448781","phase":"PHASE2","title":"Recombinant Human Angioendostatin /PD-1 Mab Combined With First-line Chemotherapy in the Treatment of Driver Gene Negative Advanced NSCLC","status":"UNKNOWN","sponsor":"Affiliated Cancer Hospital & Institute of Guangzhou Medical University","startDate":"2022-07-20","conditions":"Non Small Cell Lung Cancer, Endostatin","enrollment":38},{"nctId":"NCT02975479","phase":"PHASE2, PHASE3","title":"Intralymphatic Immunotherapy in Increasing Doses, Substudy","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2016-05","conditions":"Rhinitis, Allergic, Seasonal","enrollment":40},{"nctId":"NCT02061605","phase":"NA","title":"First-in-Human Safety Study Of Laser Tissue Welding For Surtureless Laparoscopic Partial Nephrectomy","status":"WITHDRAWN","sponsor":"Laser Tissue Welding, Inc.","startDate":"2016-06","conditions":"Benign Renal Tumors, Malignant Renal Tumors","enrollment":""},{"nctId":"NCT04374539","phase":"PHASE2","title":"Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial","status":"TERMINATED","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2020-04-29","conditions":"Coronavirus","enrollment":36},{"nctId":"NCT04398914","phase":"PHASE2","title":"Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2020-05-30","conditions":"Breast Cancer Invasive","enrollment":216},{"nctId":"NCT02059681","phase":"PHASE1","title":"Phase I Trial of Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO Trial)","status":"COMPLETED","sponsor":"Centro Cardiologico Monzino","startDate":"2013-12","conditions":"Chronic Myocardial Ischemia","enrollment":12}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":35,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"human albumin 5%","genericName":"human albumin 5%","companyName":"The Cleveland Clinic","companyId":"the-cleveland-clinic","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Human albumin 5% acts as a volume expander and stabilizer of blood pressure. Used for Severe blood loss or shock, Surgery, Severe burns.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}